Ernst & Young is organising the third CEO Conclave at Bio Asia 2006 where industry leaders from the bio-pharma sector will discuss on the theme 'Promise and Perils in the Pharma, Bio-pharma and Biotechnology industry in India' on February 10, 2006 at Taj Residency, Hyderabad.

In the previous editions of CEO Conclave, leaders of the industry made presentations and commented on their perspective of the path that the industry has taken. In the current year, E & Y has planned to organise a panel discussion of industry leaders.

Key speakers who will take part in the panel discussion will include Kewal Handa, Pfizer; Habil Khorakiwala, Wockhardt; Andrew Mascarenhas, OneWorldHealth; Dr Krishna Ella, Bharat Biotech; Sanjiv Kaul, Chrys Capital; Calab Gabriel, KNS Partners; and Sanjay Reddy, GVK Biosciences.

Ernst & Young will also unveil 'Health Quotient', a report on the 'Issues and Opportunities in the Indian Pharma, Biotech and Healthcare Sectors.'